November 2, 2023
Pharmazac has released the new product Ractilen (rasagiline tabs 1mg/tab ) for the treatment of PD
November 2, 2023
Pharmazac has released the new product Nitastin 20mg film coated tablet for treatment of heart disease In addition to the hypolipidemic actions Nitastin has beneficial effects […]
November 2, 2023
Pharmazac launched the first Rosuvastatin generic in the Greek Pharmaceutical Market. Rosuvastatin is available in two forms of 14 and 30 film coated tablets and composition of […]
November 2, 2023
November 2, 2023
Pharmazac a Member of the Hellenic Association of Pharmaceutical Companies, announces the completion of the successful Conference of the Hellenic Society of Headache, that took place […]
November 2, 2023
Pharmazac launched the new product Quental/quetiapine 50,200,300 and 400mg in prolonged release tablets for the treatment of schizophrenia and bipolar disorders.
November 2, 2023
Pharmazac launched Etrozac / etoricoxib a selective cyclo-oxygenase – 2 (COX-2) inhibitor. Etrozac indicated for the treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute pain and […]
November 2, 2023
Pharmazac has developed in its laboratories and launched in the Greek pharmaceutical market a nutraceutical, the titrate extract of Petasitis Hybridus in liquid hard gelatin capsules […]
November 2, 2023